Series 3: Nuances of Market Access – Future-Proofing
Update: 2025-08-25
Description
Part 3 takes on the evolving market access landscape in the dynamic U.S. healthcare system.
With value delivery at the forefront, this discussion examines how companies can measure and demonstrate value, the critical interplay between FDA and CMS on value propositions, and practical strategies for engaging payers.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
